Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cambridge University Hospitals NHS Foundation Trust
With
Roche Pharma AG
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Diagnosis of SLE or ANCA associated vasculitis
2. Active disease refractory to 6 months conventional therapy with cyclophosphamide, prednisolone and at least one other immunosupressive agent ( or a lesser period if this therapy cannot be tolerated)
3. Age 18-70
You may not be if
1. HbeAg or HCV Ab positive or known HIV positivity ( HIV testing not necessary for this study)
2. Pregnancy, inadequate contraception or lactation
3. Malignancy
4. Current enrolment in pother clinicla trials -
Clareo Health | Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
